Civi Biopharma Incis A Us Basedprivately Held Biopharmaceutical Companyfounded In 2016The Company S Research And Development Activities Are Focused On Creating Novel Therapies For Cardiovascularmetabolic And Related Diseasescivi S Innovative Pipeline Includes Civi007A Long Acting Pcsk9 Third Generation Locked Nucleic Acid Antisense Molecule Being Developed For The Treatment Of Hypercholesterolemia And The Prevention Of Cardiovascular Disease In Additionthe Company Currently Has Other Clinical Stage Development Program Activity Aimed At Treating Severe Liver Diseases
